Ivy D D, Kinsella J P, Abman S H
Division of Cardiology, University of Colorado School of Medicine, Denver, USA.
J Appl Physiol (1985). 1996 Dec;81(6):2481-7. doi: 10.1152/jappl.1996.81.6.2481.
The physiological role of endothelin-1 (ET-1) in regulation of vascular tone in the perinatal lung is controversial. Recent studies suggest that ET-1 contributes to high basal pulmonary vascular resistance in the normal fetus, but its role in the modulation of pulmonary vascular tone remains uncertain. We hypothesized that high ET-1 activity opposes the vasodilator response to some physiological stimuli such as increased pressure. To test the hypothesis that ET-1 modulates fetal pulmonary vascular responses to acute and prolonged physiological stimuli, we performed a series of experiments in the late-gestation ovine fetus. We studied the hemodynamic effects of two ET-1 antagonists, BQ-123 (a selective ETA-receptor antagonist) and phosphoramidon (a nonselective ET-1-converting enzyme inhibitor) during mechanical increases in pressure due to partial ductus arteriosus compression in chronically prepared late-gestation fetal lambs. In control studies, partial ductus arteriosus compression decreased the ratio of pulmonary arterial pressure to pulmonary artery flow in the left lung 34 +/- 6% from baseline. Intrapulmonary infusions of BQ-123 (0.5 microgram/min for 10 min; 0.025 microgram/min for 2 h) or phosphoramidon (1.0 mg/min for 10 min) augmented the peak vasodilator response during ductus arteriosus compression (52 +/- 3 and 49 +/- 6% from baseline, respectively, P < 0.05 vs. control). In addition, unlike the transient vasodilator response to ductus arteriosus compression in control studies, ET-1 blockade with BQ-123 or phosphoramidon prolonged the increase in flow caused by ductus arteriosus compression. In summary, ETA-receptor blockade and ET-1-converting enzyme inhibition augment and prolong fetal pulmonary vasodilation during partial compression of the ductus arteriosus. We conclude that ET-1 activity modulates acute and prolonged responses of the fetal pulmonary circulation to changes in vascular pressure. We speculate that ET-1 contributes to regulation and maintenance of high pulmonary vascular resistance in the normal ovine fetal lung.
内皮素-1(ET-1)在围产期肺血管张力调节中的生理作用存在争议。最近的研究表明,ET-1促成正常胎儿的高基础肺血管阻力,但其在调节肺血管张力中的作用仍不确定。我们假设高ET-1活性会对抗对某些生理刺激(如压力增加)的血管舒张反应。为了验证ET-1调节胎儿肺血管对急性和长期生理刺激反应的假设,我们在妊娠晚期绵羊胎儿中进行了一系列实验。我们研究了两种ET-1拮抗剂BQ-123(一种选择性ETA受体拮抗剂)和磷酰胺素(一种非选择性ET-1转换酶抑制剂)在慢性制备的妊娠晚期胎儿羔羊因部分动脉导管受压导致压力机械性增加期间的血流动力学效应。在对照研究中,部分动脉导管受压使左肺肺动脉压与肺动脉血流比值较基线降低34±6%。肺内输注BQ-123(0.5微克/分钟,持续10分钟;0.025微克/分钟,持续2小时)或磷酰胺素(1.0毫克/分钟,持续10分钟)可增强动脉导管受压期间的峰值血管舒张反应(分别较基线增加52±3%和49±6%,与对照组相比,P<0.05)。此外,与对照研究中对动脉导管受压的短暂血管舒张反应不同,用BQ-123或磷酰胺素阻断ET-1可延长动脉导管受压引起的血流增加时间。总之,ETA受体阻断和ET-1转换酶抑制可增强并延长动脉导管部分受压期间的胎儿肺血管舒张。我们得出结论,ET-1活性调节胎儿肺循环对血管压力变化的急性和长期反应。我们推测ET-1有助于正常绵羊胎儿肺中高肺血管阻力的调节和维持。